drugset / Trial / NCT00980031
Aldosterone Blockade to Prevent Myocardial Remodeling In Patients With Controlled Essential Hypertension
RandomizedParallel-groupTriple-blindPrevention
Summary
The goal of this project is to investigate the effects that the addition of aldosterone blockade with eplerenone will have on the progression of diastolic dysfunction in patients with controlled essential hypertension.
Timeline
- Start
- 2007-04
- Primary completion
- 2011-09
- Completion
- 2011-09
Outcome
Outcome not reported
Stopped (Business): “Funding ended prior to study completion”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Eplerenone | Unknown | 25 mg | Oral |
Indications
No indication recorded.